180 Life Sciences Corp. announced a private placement to issue pre-funded warrants to purchase 1,111,878 shares of common stock for $111.19 of cash on February 21, 2024. The exercise of the warrants was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

The resale of the shares of common stock issuable upon exercise of the warrants was registered under a registration statement declared effective under the Securities Act. After the issuance, the company will have 11,270,710 shares of common stock issued and outstanding.